Furthermore, blocking treatments with anti-RAGE antibody could significantly inhibit the osteogenic differentiation of A7r5 smooth muscle cells induced by CML under high-lipid, apoptosis-coexisting conditions. This evidence concerns the gene AGER and chronic myelogenous leukemia, BCR-ABL1 positive.